News & Views
BACH 1 Inhibitors could be Key for Blood Vessel Growth
Feb 18 2020
A new method for stimulating the growth of new blood vessels in the heart thus increasing blood flow to damaged tissue, will be investigated by researchers at the University of Bristol with funding of over £100,000 from national charity Heart Research UK.
.A team, led by Professor Paolo Madeddu, Chair of Experimental Cardiovascular Medicine at Bristol, discovered that an excess of a protein called BACH1 can prevent blood vessel formation. They hope to show that the use of BACH1 inhibitors can stimulate the growth of new blood vessels and if successful lead to development of drug treatments for heart disease. The treatment could also benefit people suffering from other diseases such as poor blood circulation in the legs, or damage to other organs, such as the kidney, brain and eyes.
Professor Madeddu said: "The use of BACH1 inhibitors is a very promising area of study that promises to have a huge impact on the way that we treat a wide range of conditions.
"If we are successful, the door will be opened for a whole new method of treating people who have suffered damage to their hearts. The ability to stimulate the growth of new blood vessels will allow us to drastically improve the quality of life of patients who may be at risk of heart failure. We're very grateful to Heart Research UK for allowing us to undertake this research."
Digital Edition
ILM 49.5 July
July 2024
Chromatography Articles - Understanding PFAS: Analysis and Implications Mass Spectrometry & Spectroscopy Articles - MS detection of Alzheimer’s blood-based biomarkers LIMS - Essent...
View all digital editions
Events
Jul 28 2024 San Diego, CA USA
Jul 30 2024 Jakarta, Indonesia
Jul 31 2024 Chengdu, China
ACS National Meeting - Fall 2024
Aug 18 2024 Denver, CO, USA
Aug 25 2024 Copenhagen, Denmark